Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hauer

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Chemical Research in Toxicology|December 1, 1996
Bioactivation of 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-d]pyrimidine (U-89843) to reactive intermediates that bind covalently to macromolecules and produce genotoxicityZ Zhao, K A Koeplinger, G E Padbury, et al.
JAMA|May 18, 1999
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian BiodefenseT V Inglesby, D A Henderson, J G Bartlett, et al.
JAMA|June 15, 1999
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian BiodefenseD A Henderson, T V Inglesby, J G Bartlett, et al.
Journal of the American Heart Association|May 10, 2017
Age-Specific Vascular Risk Factor Profiles According to Stroke SubtypeAllard J Hauer, Ynte M Ruigrok, Ale Algra, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 17, 2001
Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjectsJ G Slatter, D J Stalker, K L Feenstra, et al.
The International Journal of Cardiovascular Imaging|June 16, 2017
A systematic comparison of cardiovascular magnetic resonance and high resolution histological fibrosis quantification in a chronic porcine infarct modelJohannes M I H Gho, René van Es, Frebus J van Slochteren, et al.
Journal of the American Society of Nephrology : JASN|August 19, 2015
High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 GlomerulopathiesFengxiao Bu, Nicolo Ghiringhelli Borsa, Michael B Jones, et al.
JAMA|March 7, 2001
Botulinum toxin as a biological weapon: medical and public health managementS S Arnon, R Schechter, T V Inglesby, et al.
JAMA|June 21, 2001
Tularemia as a biological weapon: medical and public health managementD T Dennis, T V Inglesby, D A Henderson, et al.
JAMA|May 12, 2000
Plague as a biological weapon: medical and public health management. Working Group on Civilian BiodefenseT V Inglesby, D T Dennis, D A Henderson, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Chemical Research in Toxicology|December 1, 1996
Bioactivation of 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-d]pyrimidine (U-89843) to reactive intermediates that bind covalently to macromolecules and produce genotoxicityZ Zhao, K A Koeplinger, G E Padbury, et al.
JAMA|May 18, 1999
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian BiodefenseT V Inglesby, D A Henderson, J G Bartlett, et al.
JAMA|June 15, 1999
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian BiodefenseD A Henderson, T V Inglesby, J G Bartlett, et al.
Journal of the American Heart Association|May 10, 2017
Age-Specific Vascular Risk Factor Profiles According to Stroke SubtypeAllard J Hauer, Ynte M Ruigrok, Ale Algra, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 17, 2001
Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjectsJ G Slatter, D J Stalker, K L Feenstra, et al.
The International Journal of Cardiovascular Imaging|June 16, 2017
A systematic comparison of cardiovascular magnetic resonance and high resolution histological fibrosis quantification in a chronic porcine infarct modelJohannes M I H Gho, René van Es, Frebus J van Slochteren, et al.
Journal of the American Society of Nephrology : JASN|August 19, 2015
High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 GlomerulopathiesFengxiao Bu, Nicolo Ghiringhelli Borsa, Michael B Jones, et al.
JAMA|March 7, 2001
Botulinum toxin as a biological weapon: medical and public health managementS S Arnon, R Schechter, T V Inglesby, et al.
JAMA|June 21, 2001
Tularemia as a biological weapon: medical and public health managementD T Dennis, T V Inglesby, D A Henderson, et al.
JAMA|May 12, 2000
Plague as a biological weapon: medical and public health management. Working Group on Civilian BiodefenseT V Inglesby, D T Dennis, D A Henderson, et al.
Pageof 8